LGALS3 and type 2 diabetes mellitus: Seferovic et al. demonstrated that elevated galectin-3 levels correlated with NT-proBNP and left ventricular mass in patients with T2DM and hypertension without ischemic or HF symptoms, suggesting the potential role of galectin-3 in the detection of early myocardial structural remodeling [36].